Vortex Therapeutics Inc.
Lombard, IL
- UEI
- QY5RU47AZ7J8
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 332 E Central Ave, Lombard, IL 60148, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of a novel MYC inhibitor for cancer therapy - summary MYC proteins (including c-MYC, n-MYC and l-MYC) are… | National Cancer Institute | $3,347,703 |
Quick answers
What is Vortex Therapeutics Inc.'s UEI?
Vortex Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is QY5RU47AZ7J8.
Where is Vortex Therapeutics Inc. located?
Vortex Therapeutics Inc.'s physical address in SAM.gov is 332 E Central Ave, Lombard, IL 60148, USA.
Is Vortex Therapeutics Inc. registered in SAM.gov?
Yes. Vortex Therapeutics Inc.'s SAM.gov registration is active through June 9, 2027.
What is Vortex Therapeutics Inc.'s most recent federal award?
Vortex Therapeutics Inc.'s most recent federal grant award is Development of a novel MYC inhibitor for cancer therapy - summary MYC proteins (including c-MYC, n-MYC and l-MYC) are… (R44CA302283), from National Cancer Institute, on September 12, 2025.
On GovTribe
See Vortex Therapeutics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors